Grow your business safely with PHARMA DIRECT

All the information you need about PHARMA DIRECT to develop and secure your business in France

P HOME > CORPORATES > PHARMA DIRECT > BALANCE SHEET ( 2017-08-24)

THE LIST OF BALANCE SHEET : PHARMA DIRECT

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2021-10-22 Public 2020-12-31 Complete
2020-09-18 Public 2019-12-31 Complete
2019-08-22 Public 2018-12-31 Complete
2018-09-25 Public 2017-12-31 Complete
2017-08-24 Public 2016-12-31 Complete
NamePHARMA DIRECT
Siren340305390
Closing2016-12-31
Registry code 8303
Registration number 4572
Management number1987B00045
Activity code 4619A
Closing date n-12015-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2017-08-24
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address83600 Fréjus
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 840.00 840.00 840.00
AT Other tangible assets 23 223.00 13 095.00 10 128.00 23 223.00
BH Other financial assets 3 884.00 3 884.00 3 884.00
BJ TOTAL (I) 27 947.00 13 935.00 14 011.00 27 947.00
BT Goods 136 710.00 136 710.00 136 710.00
BX Customers and related accounts 712 831.00 712 831.00 712 831.00
BZ Other receivables 284 265.00 284 265.00 284 265.00
CF Cash and cash equivalents
CH Prepaid expenses 672.00 672.00 672.00
CJ TOTAL (II) 1 134 478.00 1 134 478.00 1 134 478.00
CO Grand total (0 to V) 1 162 425.00 13 935.00 1 148 490.00 1 162 425.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 14 830.00 15 130.00 14 830.00
DD Legal reserve (1) 2 633.00 1 348.00 2 633.00
DH Retained earnings 40 814.00 40 814.00 40 814.00
DI RESULTS FOR THE YEAR (Profit or Loss) 34 270.00 25 704.00 34 270.00
DL TOTAL (I) 92 547.00 82 995.00 92 547.00
DU Loans and Debts from Credit Institutions (3) 31 505.00 347.00 31 505.00
DV Miscellaneous Loans and Financial Debts (4) 224.00 224.00 224.00
DX Trade payables and related accounts 930 418.00 897 827.00 930 418.00
DY Tax and social security liabilities 86 581.00 124 445.00 86 581.00
EA Other liabilities 7 214.00 2 057.00 7 214.00
EC TOTAL (IV) 1 055 943.00 1 024 899.00 1 055 943.00
EE Grand total (I to V) 1 148 490.00 1 107 894.00 1 148 490.00
EG Accrued income and payables due within one year 1 055 943.00 1 024 899.00 1 055 943.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FA Sales of goods 2 064 300.00 2 064 300.00 2 064 300.00
FG Production sold - services 547 404.00 547 404.00 547 404.00
FJ Net sales 2 611 704.00 2 611 704.00 2 611 704.00
FP Reversals of depreciation and provisions, transfer of expenses
FQ Other income 39.00
FR Total operating income (I) 2 611 742.00
FS Purchases of goods (including customs duties) 1 965 133.00
FT Inventory change (goods) 6 430.00
FW Other purchases and external expenses 490 990.00
FX Taxes, duties, and similar payments 3 136.00
FY Salaries and Wages 80 429.00
FZ Social Security Contributions 21 972.00
GA Operating Expenses - Depreciation and Amortization 2 437.00
GE Other Expenses 55.00
GF Total Operating Expenses (II) 2 570 581.00
GG - OPERATING RESULT (I - II) 41 162.00
GR Interest and similar expenses 703.00
GU Total financial expenses (VI) 703.00
GV - FINANCIAL INCOME (V - VI) -703.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 40 458.00
4 - Income statement (continued)Amount year NAmount year N-1
HE Exceptional expenses on management operations 738.00 195.00 738.00
HH Total exceptional expenses (VIII) 738.00 195.00 738.00
HI - EXCEPTIONAL RESULT (VII - VIII) -738.00 -195.00 -738.00
HK Income tax 5 450.00 3 782.00 5 450.00
HL TOTAL REVENUE (I + III + V + VII) 2 611 742.00 2 757 077.00 2 611 742.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 2 577 472.00 2 731 373.00 2 577 472.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 34 270.00 25 704.00 34 270.00

all companies in France

Complete and comprehensive database.